Concept Lead score
Multiple Myeloma 1 1
Biologic Therapy 0 0.95
Refractory 0 0.98
CAR-T 0 0.64
Immunotherapy 0 0.99
Targeted Cancer Therapy 0 0.22
Non-Hodgkin Lymphoma (NHL) 0 0.19
Hodgkin Lymphoma 0 0.17
Patient Safety 0 0.14
B-Cell Lymphoma 0 0.13
Adverse Effects 0 0.12
Antigens 0 0.12
Lymphoma 0 0.12
Proteasome Inhibitor 0 0.12
Receptors 0 0.12
Leukemia 0 0.09
Healthcare and Medical Technology 0 0.07
Antibody Drug Conjugates 0 0.06
Antiemetic 0 0.06
Arizona 0 0.06
Cancer 0 0.06
Clinical Research 0 0.06
Face 0 0.06
Hematology 0 0.06
Immunomodulator 0 0.06
Medical Oncology 0 0.06
Nausea 0 0.06
New York 0 0.06
Specialty Lead score
Hematology-Oncology 1 1
Allergy & Clinical Immunology 0 0.9